Actionable news
All posts from Actionable news
Actionable news in NBIX: Neurocrine Biosciences, Inc.,

Perilous Reversal Stock: Neurocrine Biosciences (NBIX)

Trade-Ideas LLC identified Neurocrine Biosciences ( NBIX) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Neurocrine Biosciences as such a stock due to the following factors:

  • NBIX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $91.4 million.
  • NBIX has traded 78,563 shares today.
  • NBIX is down 3.6% today.
  • NBIX was up 12% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in NBIX with the Ticky from Trade-Ideas. See the FREE profile for NBIX NOW at Trade-Ideas More details on NBIX: Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. Currently there are 8 analysts that rate Neurocrine Biosciences a buy, no analysts rate it a sell, and none rate it a hold. The average volume...